Find Hope and Relief

Comprehensive Esketamine Treatment in Forsyth County, GA

At New Focus Addiction and Behavioral Health, we understand the challenges of living with treatment-resistant depression (TRD) and the burden they can place on individuals and their loved ones. That’s why we are proud to offer SPRAVATO®, a groundbreaking prescription medicine that provides hope and relief for those struggling with TRD and depressive symptoms.

Call Us Today

More Information on SPRAVATO®

SPRAVATO® is a prescription medicine that, when used in combination with an antidepressant, effectively treats TRD and depressive symptoms in adults with major depressive disorder (MDD) who experience suicidal thoughts or actions. Unlike traditional antidepressants, SPRAVATO® targets the N-methyl-D-aspartate (NMDA) receptor in the brain, which plays a crucial role in regulating mood and emotions.

In clinical studies, SPRAVATO® has demonstrated remarkable efficacy, with patients experiencing a reduction in depressive symptoms as early as 24 hours after the first dose. This continued improvement over time brings new hope to individuals who have previously faced limited options.

Is SPRAVATO® Right For You?

If you have been diagnosed with TRD, major depressive disorder, and are struggling with suicidal thoughts or actions, SPRAVATO® may be the breakthrough treatment you’ve been seeking. Our dedicated team of medical professionals will evaluate your specific circumstances, medical history, and treatment goals to determine if SPRAVATO® is a suitable option for you.

Why SPRAVATO®?

SPRAVATO® offers a new approach to treating treatment-resistant depression by directly targeting the NMDA receptor, setting it apart from traditional antidepressants. Its unique mechanism of action has shown promising results in clinical studies, providing rapid and sustained relief from depressive symptoms. The profound impact of SPRAVATO® on the lives of patients who have not responded to other treatments is undeniable.

How Treatment Works

We offer SPRAVATO® treatment administered as a nasal spray under medical supervision. Each dose consists of two sprays, one in each nostril, allowing for convenient and efficient delivery of the medication. However, it is important to note that SPRAVATO® can cause sedation and dissociation, which is why professional supervision is critical during treatment.